CI

At a glance

ClinicalIndex Comparison Record
N/ACompleted· 37,939 enrolled
Drug / intervention
Not specified
Likely dose
Not stated in record
Structured eligibility isn't available for this trial yet — see the full criteria in the Eligibility tab below.

Standardized by ClinicalIndex from the ClinicalTrials.gov record · verify against the source.

Search/NCT00563901
NCT00563901N/ACompleted
CompareCT.gov

GenHAT - Genetics of Hypertension Associated Treatments - Ancillary to ALLHAT

University of Alabama at Birmingham·observational·Posted Nov 26, 2007·Updated Mar 4, 2014

In Brief

An observational study for Hypertension and 2 related conditions. Completed, enrolled 37,939 participants across 2 sites.

Detailed Summary

High blood pressure is one of the most common health problems in the United States. There are many medications to treat high blood pressure, but there is a large variance in how people respond to these medications. It is believed that genetic variations may contribute to the inconsistent treatment response. This study will use genetic analysis to determine whether particular genes interact with high blood pressure medications to modify the risk of certain cardiovascular diseases.

Study Details

Study Typeobservational
Allocation--
Masking--
Primary Purpose--
ConditionsHypertension, Coronary Disease, Cerebrovascular Accident
CountriesUnited States
CollaboratorsNational Heart, Lung, and Blood Institute (NHLBI), University of Texas, University of Minnesota

Timeline

N/ACompletedFinished
2000200120022003200420052006200720082009201020112012201320142015201620172018201920202021202220232024202520262027
First PostedNov 26, 2007
Enrollment StartSep 1, 2000
Primary CompletionMay 1, 2004
TodayJul 2, 2026
Enrollment to primary: 3.7 yearsPosted 18.6 years ago